APA (7th ed.) Citation

Y, L., CAB, P., FG, S., RC, B., JH, K., S, F., . . . K, A. (2022). Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis. The Lancet regional health. Europe, 17, 100381. https://doi.org/10.1016/j.lanepe.2022.100381

Chicago Style (17th ed.) Citation

Y, Liu, Pearson CAB, Sandmann FG, Barnard RC, Kim JH, Flasche S, Jit M, and Abbas K. "Dosing Interval Strategies for Two-dose COVID-19 Vaccination in 13 Middle-income Countries of Europe: Health Impact Modelling and Benefit-risk Analysis." The Lancet Regional Health. Europe 17 (2022): 100381. https://doi.org/10.1016/j.lanepe.2022.100381.

MLA (9th ed.) Citation

Y, Liu, et al. "Dosing Interval Strategies for Two-dose COVID-19 Vaccination in 13 Middle-income Countries of Europe: Health Impact Modelling and Benefit-risk Analysis." The Lancet Regional Health. Europe, vol. 17, 2022, p. 100381, https://doi.org/10.1016/j.lanepe.2022.100381.